| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Evi Stavrou | |
| Alvin H Schmaier | |||
| P2860 | cites work | Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells | Q24291096 |
| Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation | Q24336585 | ||
| Contaminated heparin associated with adverse clinical events and activation of the contact system | Q24619723 | ||
| Defective thrombus formation in mice lacking coagulation factor XII | Q24646366 | ||
| Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III | Q24671677 | ||
| Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor) | Q28306231 | ||
| Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis | Q28508572 | ||
| Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes | Q28628970 | ||
| Amino acid sequence of human beta-factor XIIa | Q28631018 | ||
| Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation | Q30479254 | ||
| Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach | Q30648422 | ||
| Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells | Q32081348 | ||
| Combined cis-regulator elements as important mechanism affecting FXII plasma levels | Q34003352 | ||
| Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids | Q34169566 | ||
| Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa | Q34193071 | ||
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| Polyphosphate modulates blood coagulation and fibrinolysis. | Q34304738 | ||
| Activation of blood clotting factors by microbial proteinases | Q34323403 | ||
| Assembly of contact-phase factors on the surface of the human neutrophil membrane | Q34329853 | ||
| Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region | Q34559748 | ||
| Partial primary structure of bovine plasma fibronectin: Three types of internal homology | Q34707857 | ||
| Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor | Q34790892 | ||
| Mapping of a putative surface-binding site of human coagulation factor XII. | Q35145865 | ||
| A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma | Q35282990 | ||
| Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor | Q35592735 | ||
| The autoactivation of rabbit Hageman factor | Q36342996 | ||
| Activation of the classical pathway of complement by Hageman factor fragment | Q36344568 | ||
| The intrinsic pathway of coagulation: a target for treating thromboembolic disease? | Q36771762 | ||
| A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease | Q37361142 | ||
| Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells | Q37513781 | ||
| Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase | Q37712586 | ||
| Inhibition of activated factor XII by antithrombin-heparin cofactor | Q39404087 | ||
| Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1. | Q39447843 | ||
| Cell surface interactions with extracellular materials | Q40157123 | ||
| The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen | Q40690900 | ||
| A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation | Q42058455 | ||
| Orphan receptor hepatocyte nuclear factor-4 antagonizes estrogen receptor alpha-mediated induction of human coagulation factor XII gene | Q42463195 | ||
| Homozygosity for the C-->T polymorphism at nucleotide 46 in the 5' untranslated region of the factor XII gene protects from development of acute coronary syndrome | Q43695448 | ||
| Homozygosity of the T allele of the 46 C->T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population. | Q43771274 | ||
| Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects | Q44019600 | ||
| Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study | Q44123484 | ||
| John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study | Q44652745 | ||
| Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies | Q45205740 | ||
| Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. | Q45279377 | ||
| Dual role of collagen in factor XII-dependent thrombus formation | Q46048146 | ||
| Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease | Q46695250 | ||
| Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells. | Q53670507 | ||
| Activation of blood clotting factors by microbial proteinases | Q56706175 | ||
| Ordered adsorption of coagulation factor XII on negatively charged polymer surfaces probed by sum frequency generation vibrational spectroscopy | Q57974758 | ||
| Partial Identification of the Zn2+-Binding Sites in Factor XII and its Activation Derivatives | Q59541864 | ||
| The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism | Q67939877 | ||
| Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor | Q68826238 | ||
| Epidermal growth factor | Q68951248 | ||
| Identification and characterization of a binding site for factor XIIa in the Apple 4 domain of coagulation factor XI | Q70578873 | ||
| Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII | Q70596348 | ||
| Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces | Q71149636 | ||
| Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein | Q71570789 | ||
| Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator | Q71585817 | ||
| Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor) | Q71607317 | ||
| Molecular basis of estrogen regulation of Hageman factor XII gene expression | Q71813069 | ||
| The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein | Q71939378 | ||
| Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation | Q73763204 | ||
| Factor XII does not initiate prekallikrein activation on endothelial cells | Q74823530 | ||
| The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces | Q77620528 | ||
| The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies | Q78981048 | ||
| Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression | Q82152526 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| pathophysiology | Q1135939 | ||
| P304 | page(s) | 210-5 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis | |
| P478 | volume | 125 |
| Q50683175 | A coupled chemo-fluidic computational model for thrombogenesis in infarcted left ventricles. |
| Q33737314 | A novel missense mutation in the factor XII gene in a litter of cats with factor XII deficiency |
| Q39539762 | A plasma proteolysis pathway comprising blood coagulation proteases |
| Q42601092 | Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats |
| Q35561035 | Amidolytic, procoagulant, and activation-suppressing proteins produced by contact activation of blood factor XII in buffer solution. |
| Q37897474 | Arterial thrombus formation in cardiovascular disease |
| Q38688610 | Assessment of the protein interaction between coagulation factor XII and corn trypsin inhibitor by molecular docking and biochemical validation |
| Q55305378 | Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis. |
| Q42551076 | Contact activation of blood coagulation on a defined kaolin/collagen surface in a microfluidic assay |
| Q34473963 | Effect of nano-scale curvature on the intrinsic blood coagulation system |
| Q35535831 | Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk. |
| Q34845482 | Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system |
| Q39886396 | FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis |
| Q37636983 | Factor XII inhibition reduces thrombus formation in a primate thrombosis model |
| Q38860396 | Factor XII: form determines function |
| Q39322760 | Flow chamber and microfluidic approaches for measuring thrombus formation in genetic bleeding disorders |
| Q35145682 | Genetic divergence between populations of feral and domestic forms of a mosquito disease vector assessed by transcriptomics |
| Q35172654 | Heparan sulfate proteoglycans mediate factor XIIa binding to the cell surface |
| Q37876411 | Inherited disorders of blood coagulation |
| Q42922540 | Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer |
| Q38117200 | Kininogen-dependent antiphosphatidylethanolamine antibodies and autoantibodies to factor XII in patients with recurrent pregnancy losses |
| Q42011864 | Localization of Short-Chain Polyphosphate Enhances its Ability to Clot Flowing Blood Plasma. |
| Q46898343 | Molecular characterization of cat factor XII gene and identification of a mutation causing factor XII deficiency in a domestic shorthair cat colony |
| Q84784468 | Novel deleterious mutation in the F12 gene in a Korean family with severe coagulation factor XII deficiency |
| Q38014345 | Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT. |
| Q92670224 | Polyphosphate, Zn2+ and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting |
| Q45933825 | Reduced Blood Coagulation on Roll-to-Roll, Shrink-Induced Superhydrophobic Plastics. |
| Q47900623 | Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex |
| Q37665209 | Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer. |
| Q35905607 | The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats |
| Q38632499 | The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities |
| Q26775616 | The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities |
| Q38106741 | The kinin-kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers. |
| Q37853060 | The many faces of the contact pathway and their role in thrombosis |
| Q99623622 | The multifaceted role of plasminogen in inflammation |
| Q91768594 | Transferrin plays a central role in coagulation balance by interacting with clotting factors |
Search more.